Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tissue plasminogen activator.

× No keyword cloud information.

29 in total

1. Tissue plasminogen activator in the treatment of superior vena caval thrombosis associated with parenteral nutrition.

Authors: G R Barclay; K Allen; C R Pennington
Journal: Postgrad Med J Date: 1990-05 Impact factor: 2.401

2. A recombinant chimeric plasminogen activator with high affinity for fibrin has increased thrombolytic potency in vitro and in vivo.

Authors: M S Runge; T Quertermous; P J Zavodny; T W Love; C Bode; M Freitag; S Y Shaw; P L Huang; C C Chou; D Mullins
Journal: Proc Natl Acad Sci U S A Date: 1991-11-15 Impact factor: 11.205

Review 3. Recombinant DNA and surgery.

Authors: J M Brown; A H Harken; J B Sharefkin
Journal: Ann Surg Date: 1990-08 Impact factor: 12.969

4. Tissue plasminogen activator reverses the deleterious effect of infection on colonic wound healing.

Authors: K A Houston; D I McRitchie; O D Rotstein
Journal: Ann Surg Date: 1990-02 Impact factor: 12.969

5. Lumenal protein within secretory granules affects fusion pore expansion.

Authors: Annita Ngatchou Weiss; Arun Anantharam; Mary A Bittner; Daniel Axelrod; Ronald W Holz
Journal: Biophys J Date: 2014-07-01 Impact factor: 4.033

6. Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbits.

Authors: D E Vaughan; P J Declerck; M De Mol; D Collen
Journal: J Clin Invest Date: 1989-08 Impact factor: 14.808

7. A lethal phenotype associated with tissue plasminogen deficiency in humans.

Authors: Hanan E Shamseldin; Abdulrahman Aldeeri; Zainab Babay; Abdulrahman Alsultan; Mais Hashem; Fowzan S Alkuraya
Journal: Hum Genet Date: 2016-07-14 Impact factor: 4.132

8. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by Rickettsia conorii- and Rickettsia rickettsii-infected cultured endothelial cells.

Authors: M Drancourt; M C Alessi; P Y Levy; I Juhan-Vague; D Raoult
Journal: Infect Immun Date: 1990-08 Impact factor: 3.441

9. The use of thrombolytic therapy in pregnancy.

Authors: Eric J Gartman
Journal: Obstet Med Date: 2013-07-25

Review 10. Evaluation of thrombolytic agents.

Authors: W R Bell
Journal: Drugs Date: 1997 Impact factor: 9.546